Skip to main content
. 2011 Nov 10;7(11):e1002226. doi: 10.1371/journal.pcbi.1002226

Figure 7. R105/106A ARPC4 mutant nucleates actin filaments without nucleation promoting factors.

Figure 7

(a) Recombinant Arp2/3 complex WT (rWT) and R105/106A ARPC4 expressed and purified from sf21 cells. (b) Pyrene actin assembly assays comparing nucleation activity of rWT and R105/106A ARPC4 rArp2/3 complex. (c) Pointed end capping assay with actin alone (black), rWT (red) and R105/106A ARPC4 rArp2/3 (green), and R105/106A ARPC4 rArp2/3 pretreated with Antarctic phosphatase (AP-R105/106A ARPC4) (purple).